Results 91 to 100 of about 4,851,513 (185)
Measuring success in HS treatment from the physician's and the patient's perspective
Integrated clinician (HiSCR, IHS4, IHS4‐55, HS‐IGA) and patient (HiSQOL, DLQI) scores, combined with imaging‐based fibrosis and inflammation assessment, redefine treatment success in hidradenitis suppurativa by aligning treat‐to‐target strategies with both inflammatory control and irreversible structural damage.
Georgios Nikolakis +4 more
wiley +1 more source
Differential diagnosis of intestinal Behçet's disease and Crohn's disease by colonoscopic findings
BACKGROUND AND STUDY AIMS: Intestinal Behçet's disease and Crohn's disease are chronic inflammatory bowel diseases that are difficult to distinguish from each other.
김태일 +3 more
core +1 more source
Radiosynovectomy with 188Re-Colloid in Behcet’s Patient with Drug-Resistant Arthritis: A Rare Case Report [PDF]
Behçet’s disease is a rare vasculitis that can cause arthritis refractory to standard treatments. This case report describes the use of radiosynovectomy with 188Re-colloid in a patient with drug-resistant Behçet’s arthritis. A 33-year-old man with Behçet’
Esmaeil Gharepapagh +3 more
doaj +1 more source
Treatment strategies for interstitial granulomatous dermatitis: Systematic review and expert opinion
Systematic review of 108 studies with a total of 182 patients with interstitial granulomatous dermatitis (IGD). IGD was frequently associated with systemic conditions or drug exposure. Management includes careful medication review and prompt withdrawal of potential triggers. Corticosteroids (systemic and topical) were commonly effective, while biologic
Francesco Bellinato +4 more
wiley +1 more source
This systematic review evaluated drug‐target Mendelian randomisation studies on periodontitis. Twelve studies identified host‐response‐related targets mainly involved in inflammatory, complement, and immune pathways. Although some targets were linked to existing drugs, the evidence remains preliminary and heterogeneous, requiring replication and ...
Luigi Nibali +4 more
wiley +1 more source
Use of gevokizumab for the treatment of Behçet's disease
Introduction: Behçet's disease is a rare systemic autoinflammatory disorder of unknown aetiology. The hetereogenous clinical presentation makes treatment with standardised regimes a challenge and routine immunosuppressant therapies may render patients ...
McDermott, Michael F. +5 more
core +1 more source
Introduction Behçet’s disease commonly presents with recurrent oral and genital mucocutaneous ulcerations, uveitis and various skin manifestations. Other clinical symptoms include gastrointestinal ulcerations, arthritis, venous thrombosis, arterial ...
Wagner Claudia +3 more
doaj +1 more source
AI‐assisted reading with the open‐source SEE‐AI model improves lesion detection sensitivity and reduces reading time in small‐bowel capsule endoscopy. In a multicenter retrospective study of 249 cases, SEE‐AI provides visual cues that support physicians during interpretation while preserving physician‐led final decisions.
Satoshi Miyazono +19 more
wiley +1 more source
PDE4 Inhibition in Dermatologic Disease: Impacts Beyond Inflammation
This graphical abstract demonstrates the comprehensive mechanism of PDE4 inhibition in skin physiology. By increasing intracellular cAMP and activating PKA, PDE4 inhibitors exert pleiotropic effects, including immune modulation, pigmentation regulation, barrier enhancement, sensory neuron modulation, and improved wound healing with reduced fibrosis ...
Keana Khodadad +2 more
wiley +1 more source
Epidemiological and clinical features of BehÇet's disease in Korea
Behçet's disease occurs with a high prevalence in the Far East including Korea. In this report we inspected 1,155 patients with Behçet's disease and collected information concerning the clinical and epidemiologic features of Behçet's disease in Korea. In
방동식
core +1 more source

